Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition

Mostrar otras versiones (1)

Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are being developed as therapeutics and make a major contribution to the neutralizing antibody response elicited by infection. Here, we describe a deep mutational scanning method to map how all amino-acid mutations in the RBD af...

Descripción completa

Detalles Bibliográficos
Autores principales: Greaney, Allison J., Starr, Tyler N., Gilchuk, Pavlo, Zost, Seth J., Binshtein, Elad, Loes, Andrea N., Hilton, Sarah K., Huddleston, John, Eguia, Rachel, Crawford, Katharine H.D., Dingens, Adam S., Nargi, Rachel S., Sutton, Rachel E., Suryadevara, Naveenchandra, Rothlauf, Paul W., Liu, Zhuoming, Whelan, Sean P.J., Carnahan, Robert H., Crowe, James E., Bloom, Jesse D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491521/
https://www.ncbi.nlm.nih.gov/pubmed/32935107
http://dx.doi.org/10.1101/2020.09.10.292078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491521/
https://www.ncbi.nlm.nih.gov/pubmed/32935107
http://dx.doi.org/10.1101/2020.09.10.292078

Ejemplares similares